The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option

Daniel El Fassi, Claus H Nielsen, Hans K Hasselbalch, Laszlo Hegedüs

    65 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option'. Together they form a unique fingerprint.

    Medicine & Life Sciences